Publicaciones (12) Publicaciones de NURIA GARCÍA FONT

2023

  1. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  2. The activation of mGluR4 rescues parallel fiber synaptic transmission and LTP, motor learning and social behavior in a mouse model of Fragile X Syndrome

    Molecular autism, Vol. 14, Núm. 1, pp. 14

2022

  1. Ca2+ imaging of self and other in medial prefrontal cortex during social dominance interactions in a tube test

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 31

2021

  1. Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

    Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941

2020

  1. Neuroprotection by phytoestrogens in the model of deprivation and resupply of oxygen and glucose in vitro: The contribution of autophagy and related signaling mechanisms

    Antioxidants, Vol. 9, Núm. 6, pp. 1-20

  2. β-adrenergic receptors/epac signaling increases the size of the readily releasable pool of synaptic vesicles required for parallel fiber LTP

    Journal of Neuroscience, Vol. 40, Núm. 45, pp. 8604-8617

2019

  1. The loss of β adrenergic receptor mediated release potentiation in a mouse model of fragile X syndrome

    Neurobiology of Disease, Vol. 130

2016

  1. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 122, pp. 326-338

  2. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 118, pp. 178-192

2015

  1. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease

    Future Medicinal Chemistry, Vol. 7, Núm. 7, pp. 845-855

2014

  1. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9, 10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 74, pp. 491-501

2011

  1. Posibles efectos beneficiosos para la salud del fruto de mangostán

    Revista de fitoterapia, Vol. 11, Núm. 2, pp. 119-129